Tango Therapeutics (NASDAQ:TNGX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Tango Therapeutics (TNGX) operate in?

Tango Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Tango Therapeutics Stock (NASDAQ: TNGX) stock price, news, charts, stock research, profile.

Open	$2.45
Close	$2.36
Volume / Avg.	547.26K / 1.04M
Day Range	$2.35 - $2.50
52 Wk Range	2.35 - 12.10
Market Cap	$253.51M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	9.33%
Days to Cover	8.82

Recent News

Tango Therapeutics Shuts Early-Stage Cancer Study Due To Liver Toxicity

Tango Therapeutics halts its TNG348 program due to liver toxicity issues found in dose escalation studies. The company will now focus on its PRMT5 program and plans to update on TNG908 and TNG462 later this year.

Vandana Singh

Wyndham Hotels & Resorts, Olink Holding And Other Big Stocks Moving Higher On Tuesday

U.S. stocks traded lower, with the Dow Jones falling around 50 points on Tuesday. Here are some big stocks recording gains in today’s session.

Lisa Levin

Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) shares gained 64% to $0.7798 after gaining more than 10% on Friday.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep 24

Oct 24

Nov 24

Dec 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.45
Close	$2.36
Volume / Avg.	547.26K / 1.04M
Day Range	$2.35 - $2.50
52 Wk Range	2.35 - 12.10
Market Cap	$253.51M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	9.33%
Days to Cover	8.82

About Tango Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug ta...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Tango Therapeutics (TNGX) stock?

You can purchase shares of Tango Therapeutics (NASDAQ:TNGX) through any online brokerage.

View our list of the best stock brokerages

Who are Tango Therapeutics (TNGX) competitors?

Other companies in Tango Therapeutics’s space includes: Voyager Therapeutics (NASDAQ:VYGR), Korro Bio (NASDAQ:KRRO), Monopar Therapeutics (NASDAQ:MNPR), Tevogen Bio Holdings (NASDAQ:TVGN) and Sangamo Therapeutics (NASDAQ:SGMO).

What is the forecast, or price target, for Tango Therapeutics (TNGX) stock?

Tango Therapeutics has a consensus price target of $13.14.

What is the current price for Tango Therapeutics (TNGX)?

The stock price for Tango Therapeutics (NASDAQ: TNGX) is $2.36 last updated February 21, 2025 at 4:00 PM EST.

Does Tango Therapeutics (TNGX) pay a dividend?

There are no upcoming dividends for Tango Therapeutics.

When is Tango Therapeutics (NASDAQ:TNGX) reporting earnings?

Tango Therapeutics’s Q1 earnings are confirmed for Wednesday, May 7, 2025.

Is Tango Therapeutics (TNGX) going to split?

There is no upcoming split for Tango Therapeutics.

What sector and industry does Tango Therapeutics (TNGX) operate in?

Tango Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Tango Therapeutics

Tango Therapeutics (TNGX) Forecast